O
OrganOx
Normothermic organ perfusion system for liver transplantation
About OrganOx
OrganOx is a medical technology company based in Oxford, United Kingdom, with a US base in Madison, New Jersey, that develops normothermic machine perfusion systems for donor organs. The company was spun out of the University of Oxford in 2008 by transplant surgeon Professor Peter Friend and biomedical engineer Professor Constantin Coussios, through the Institute of Biomedical Engineering and the Nuffield Department of Surgical Sciences, to address the shortage of viable organs for transplantation.
Its flagship product, the OrganOx metra, is a portable, automated device for normothermic machine perfusion of donor livers. Instead of storing the organ on ice, the system keeps the liver at body temperature and continuously perfuses it with oxygenated blood and nutrients, maintaining it in a metabolically active state outside the body. This allows transplant teams to assess organ function in real time before transplantation, extend preservation times, improve transplant logistics and use organs, including those from marginal donors, that might otherwise be discarded.
The metra platform is approved for clinical use in markets including the United States, Europe, Canada and Australia and has been used in thousands of liver transplants. OrganOx supplies its devices to specialist transplant centres together with the single-use disposable perfusion sets required for each procedure, and supports hospitals with clinical training and service.
Beyond liver preservation, the company is extending its perfusion technology to kidney transplantation and to organ support applications, including work combining the metra with genetically engineered porcine livers to support patients with acute-on-chronic liver failure. Its development work focuses on broadening the use of normothermic perfusion for organ assessment, repair and enhancement.
Source: Dealroom company dataNews
Knowledge graph
Market map
600+ Global VC backed Precision Medicine startups
Market map
Healthy ageing (silver health, elderly care, longevity) Europe
Market map
Global Metabolic Health startups (Health)
Unicorn list
Health Tech & Medtech unicorns
Unicorn list
Unicorns in United Kingdom
Analysis
Europe’s first-time exits, 2024 to 2026
Sep 1, 2026
Open roles
OrganOx in the Oxford ecosystem
The OrganOx office with the hot startups, most funded companies and investors around it. Hover or tap a pin.
Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Oxford Technology
Adam Niewinski
Technikos
Royal Society Enterprise Fund
Series B and later11 investors entered at this stage
Business Growth Fund
Lauxera Capital Partners
HealthQuest Capital
Terumo
Intuitive Ventures
Longwall Ventures
Avidity Partners- SCSoleus Capital
University of Oxford
Sofina- PCPiper Heartland Healthcare Capital
Source: Dealroom Talent Intelligence.
See OrganOx on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.